Pfizer Inc. (PFE) Financials

PFE Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 207.6 billion 117.2 billion
Dec. 31, 2025 208.2 billion 121.4 billion
Sept. 30, 2025 208.7 billion 115.6 billion
June 30, 2025 206.1 billion 117.1 billion

PFE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 2.2 billion 272.0 million
Dec. 31, 2025 4.5 billion 225.0 million
Sept. 30, 2025 4.0 billion 201.0 million
June 30, 2025 -1.2 billion 203.0 million

PFE Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 2.7 billion
Dec. 31, 2025 -1.6 billion
Sept. 30, 2025 3.6 billion
June 30, 2025 2.9 billion

PFE Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 13.1 billion 60.6 billion -
Dec. 31, 2025 13.6 billion 61.6 billion 2.3 billion
Sept. 30, 2025 15.0 billion 57.4 billion -
June 30, 2025 13.2 billion 57.5 billion -

PFE Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 5.7 billion
Dec. 31, 2025 5.7 billion
Sept. 30, 2025 5.7 billion
June 30, 2025 5.7 billion

PFE Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 436.0 million 2.6 billion 3.0 billion -
Dec. 31, 2025 845.0 million 3.4 billion 3.7 billion -
Sept. 30, 2025 602.0 million 3.9 billion 3.2 billion -
June 30, 2025 618.0 million 2.4 billion 3.4 billion -

PFE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 14.5 billion 4.7 billion
Dec. 31, 2025 17.6 billion 5.3 billion
Sept. 30, 2025 16.7 billion 4.2 billion
June 30, 2025 14.7 billion 5.2 billion

PFE Revenue by Segment
Graph available only for paid members. Upgrade to see it.

PFE

List: Contenders

Price: $25.98

52 week price:
23.08
28.75

Dividend Yield: 6.78%

5-year range yield:
3.13%
7.55%

Forward Dividend Yield: 6.70%

Payout Ratio: -365.22%

Payout Ratio Range:
-1005.23%
12122.22%

Dividend Per Share: 1.72 USD

Earnings Per Share: 1.31 USD

P/E Ratio: 19.60

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United States

Volume: 23.8 million

Ebitda: 3.6 billion

Market Capitalization: 144.5 billion

Average Dividend Frequency: 4

Years Paying Dividends: 55

DGR3: 2.47%

DGR5: 2.81%

DGR10: 4.66%

DGR20: 5.27%

Links: